Cargando…

Synthesis of an Oxathiolane Drug Substance Intermediate Guided by Constraint-Driven Innovation

[Image: see text] A new route was developed for construction of the oxathiolane intermediate used in the synthesis of lamivudine (3TC) and emtricitabine (FTC). We developed the presented route by constraining ourselves to low-cost, widely available starting materials—we refer to this as supply-cente...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashinath, K., Snead, David R., Burns, Justina M., Stringham, Rodger W., Gupton, B. Frank, McQuade, D. Tyler
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574620/
https://www.ncbi.nlm.nih.gov/pubmed/33100812
http://dx.doi.org/10.1021/acs.oprd.0c00145
Descripción
Sumario:[Image: see text] A new route was developed for construction of the oxathiolane intermediate used in the synthesis of lamivudine (3TC) and emtricitabine (FTC). We developed the presented route by constraining ourselves to low-cost, widely available starting materials—we refer to this as supply-centered synthesis. Sulfenyl chloride chemistry was used to construct the framework for the oxathiolane from acyclic precursors. This bond construction choice enabled the use of chloroacetic acid, vinyl acetate, sodium thiosulfate, and water to produce the oxathiolane.